Expression and splicing mediate distinct biological signals by Søren Helweg Dam, Lars Rønn Olsen, Kristoffer Vitting-Seerup

Get full text

TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes by Guanglan Zhang, Lou Chitkushev, Lars Rønn Olsen, Derin B. Keskin, Vladimir Brusic

Get full text

Characterizing the human hematopoietic CDome by Mike Stein Barnkob, Christian eSimon, Christian eSimon, Lars Rønn Olsen

Get full text

Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using peptide block entropy by Lars Ronn Olsen, Lars Ronn Olsen, Guang Lan eZhang, Derin B Keskin, Derin B Keskin, Ellis L Reinherz, Ellis L Reinherz, Ellis L Reinherz, Vladimir eBrusic, Vladimir eBrusic

Get full text

BioReader: a text mining tool for performing classification of biomedical literature by Christian Simon, Kristian Davidsen, Christina Hansen, Emily Seymour, Mike Bogetofte Barnkob, Lars Rønn Olsen

Get full text

FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses by Christian Simon, Ulrich J. Kudahl, Jing Sun, Lars Rønn Olsen, Guang Lan Zhang, Ellis L. Reinherz, Vladimir Brusic

Get full text

Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status by Maria Rossing, Christina Bligaard Pedersen, Tove Tvedskov, Ilse Vejborg, Maj-Lis Talman, Lars Rønn Olsen, Niels Kroman, Finn Cilius Nielsen, Maj-Britt Jensen, Bent Ejlertsen

Get full text

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment by Inés Lecoq, Katharina L. Kopp, Marion Chapellier, Panagiotis Mantas, Evelina Martinenaite, Maria Perez-Penco, Lars Rønn Olsen, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen

Get full text

Building flexible and robust analysis frameworks for molecular subtyping of cancers by Christina Bligaard Pedersen, Benito Campos, Lasse Rene, Helene Scheel Wegener, Neeraja M. Krishnan, Binay Panda, Kristoffer Vitting‐Seerup, Maria Rossing, Frederik Otzen Bagger, Lars Rønn Olsen

Get full text

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients by Thomas Urup, Signe Regner Michaelsen, Lars Rønn Olsen, Anders Toft, Ib Jarle Christensen, Kirsten Grunnet, Ole Winther, Helle Broholm, Michael Kosteljanetz, Shohreh Issazadeh-Navikas, Hans Skovgaard Poulsen, Ulrik Lassen

Get full text

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients by Thomas Urup, Line Mærsk Staunstrup, Signe Regner Michaelsen, Kristoffer Vitting-Seerup, Marc Bennedbæk, Anders Toft, Lars Rønn Olsen, Lars Jønson, Shohreh Issazadeh-Navikas, Helle Broholm, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen

Get full text

cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies by Christina Bligaard Pedersen, Søren Helweg Dam, Mike Bogetofte Barnkob, Michael D. Leipold, Noelia Purroy, Laura Z. Rassenti, Thomas J. Kipps, Jennifer Nguyen, James Arthur Lederer, Satyen Harish Gohil, Catherine J. Wu, Lars Rønn Olsen

Get full text

Arginase-1-specific T cells target and modulate tumor-associated macrophages by Mads Hald Andersen, Inés Lecoq, Ayako Wakatsuki Pedersen, Evelina Martinenaite, Shamaila Munir Ahmad, Maria Perez-Penco, Lucia Lara de la Torre, Marion Chapellier, Lars Rønn Olsen, Mia Aaboe-Jørgensen, Hannah Jorinde Glöckner, Anne Mette Askehøj Rømer

Get full text

High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion by Signe Modvig, Rasmus Wernersson, Nina Friesgaard Øbro, Lars Rønn Olsen, Claus Christensen, Susanne Rosthøj, Matilda Degn, Gitte Wullf Jürgensen, Hans O. Madsen, Birgitte Klug Albertsen, Peder Skov Wehner, Steen Rosthøj, Henrik Lilljebjörn, Thoas Fioretos, Kjeld Schmiegelow, Hanne Vibeke Marquart

Get full text

Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia by Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik V. Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O'Brien Andersen, Morten Kranker Larsen, Lasse Kjær, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Hasselbalch, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen

Get full text

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings by Steven P. Treon, Camille N. Kotton, David J. Park, Giorgia Moranzoni, Camilla K. Lemvigh, Joseph C. Gathe, Tilly A. Varughese, Christopher F. Barnett, Johnny M. Belenchia, Nina M. Clark, Charles M. Farber, Muhammad Bilal Abid, Gulrayz Ahmed, Christopher J. Patterson, Maria L. Guerrera, Jacob D. Soumerai, Vipheaviny A. Chea, Isabel P. Carulli, Jackson Southard, Shuqiang Li, Catherine J. Wu, Kenneth J. Livak, Eric Holmgren, Pil Kim, Carrie Shi, Holly Lin, Vanitha Ramakrishnan, Ying Ou, Scott Olszewski, Lars Rønn Olsen, Derin B. Keskin, Derin B. Keskin, Zachary R. Hunter, Christopher Tankersley, Todd Zimmerman, Binod Dhakal

Get full text